Wolf Popper LLP Announces Investigation on Behalf of Investors in The Beauty Health Company
Tuesday, 14 November 2023 01:00 PM
Class Action
NEW YORK, NY / ACCESSWIRE / November 14, 2023 / Wolf Popper LLP is investigating potential securities fraud claims on behalf of purchasers of The Beauty Health Company ("Beauty Health") common stock (NASDAQ:SKIN).
After the market closed on November 13, 2023, Beauty Health announced weak third quarter 2023 results and lowered its full year net sales guidance 16.5% and its adjusted EBITDA margin guidance 70.3% and suspended its long-term fiscal 2025 outlook. Beauty Health blamed the poor performance on the need to stop selling its Syndeo 1.0 and 2.0 devices because of quality control issues and offered to upgrade or replace those devices with the 3.0 version. Additionally, Beauty Health disclosed its Chief Executive Officer was leaving and relinquishing his Board seat, effective November 19, 2023. On this news, Beauty Heath's intraday stock price collapsed $2.33 per share to $1.57, a drop of 59.7% on very heavy volume.
Investors who lost over $25,000 trading in Beauty Health's common stock and who would like to discuss the investigation should contact Adam Savett at (212) 451-9655, or [email protected].
Wolf Popper has successfully recovered billions of dollars for defrauded investors. Wolf Popper's reputation and expertise have been repeatedly recognized by the courts, which have appointed the firm to major positions in securities litigation. For more information about Wolf Popper, please visit the Firm's website at www.wolfpopper.com.
Attorney Advertising: Prior Results Do Not Guarantee A Similar Outcome.
Wolf Popper LLP
Adam Savett
845 Third Avenue
New York, NY 10022
Tel.: (212) 451-9655
Email: [email protected]
SOURCE: Wolf Popper LLP
